Owner QIAGEN GmbH

Convention DE 6 June 2006 30635502.7/01

Service Phillips Ormonde Fitzpatrick

Various Provisions of paragraph 44(3)(b) applied.

Filing Date 28 August 2006

Class 1 Chemical, biochemical and biotechnological products for industrial and scientific purposes in particular nucleic acids, enzymes, polymerases, reagents fo staining or marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and/or salts, distilled or purified water, silica, magnetic particles, materials for columns as well as reagents and/or solvents for sample preparation, purification, lysis, modification and/or manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances, as well as kits comprising chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and/or manipulation of cells as well as for the performance of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances, in particular nucleic acids from biological and biochemical sample material, all as far as contained in this class

Class 5 Products for medical and veterinary medical purposes, in particular diagnostic preparations, in particular nucleic acids, enzymes, polymerases, reagents for staining or marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and/or salts, distilled or purified water, silica, magnetic particles, materials for columns, chemical, biochemical and biotechnological products as well as kits comprising products for medical and veterinary medical purposes, in particular chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and/or manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances, all as far as contained in this class, but specifically excluding pharmaceutical products and technologies for the prevention or treatment of human diseases or human health-related conditions and for diagnosis to identify human patient populations appropriate for administration of preventatives or therapeutics and to monitor response thereto

Class 9 Scientific apparatus, instruments and equipment, in particular for research, development and examination purposes as well as laboratory equipment, analytical instruments, in particular for sample preparation, modification and manipulation of cells as well as for the performance of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, proteins, macro molecules and bio logically active substances, in particular nucleic acids from biological and biochemical sample material, chromatography columns, robots and automated laboratory equipment and spare parts and add-ons, in particular pre-programmed cards, micro plates, pipettes, pipette tips, pipette tip holders, sample containers, reagent holders, flasks, containers, reagent tube holders, holders for micro containers, magnetic particles, magnetic syringes, biochips, as well as thermocyclers, homogenizers, vacuum valves, all as far as contained in this class

Class 42 Services related to scientific research and development, in particular services in the field of research, development and diagnostics in the field of chemistry, genetics, biology and biochemistry services as well as diagnostic services in the field of DNA, RNA and protein detection and analysis, services in the field of forensics as well as design for others in the field of chemistry, genetics, biology and biochemistry, all as far as contained in this class, but specifically excluding research and development, discovery, design and testing of pharmaceutical products and technologies for the prevention or treatment of human health-related conditions for diagnosis to identify human patient populations appropriate for administration of preventatives or therapeutics and to monitor response thereto